Voyager Therapeutics, Inc.
VYGR
$3.77
-$0.18-4.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 208.93M | 215.59M | 236.02M | 266.68M | 345.36M |
| Total Receivables | 4.04M | 2.53M | 2.11M | 4.49M | 19.67M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.62M | 9.77M | 7.08M | 428.00K | 8.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 5.21M | -- |
| Total Current Assets | 219.59M | 227.89M | 245.21M | 276.81M | 373.44M |
|
|
|||||
| Total Current Assets | 219.59M | 227.89M | 245.21M | 276.81M | 373.44M |
| Net Property, Plant & Equipment | 43.03M | 44.89M | 46.06M | 47.66M | 49.72M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.61M | 2.87M | 2.87M | 2.87M | 2.87M |
| Total Assets | 288.31M | 322.10M | 353.24M | 393.05M | 426.04M |
|
|
|||||
| Total Accounts Payable | 2.12M | 1.80M | 2.63M | 4.00M | 3.16M |
| Total Accrued Expenses | 14.95M | 12.03M | 9.05M | 14.17M | 11.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.85M | 7.64M | 7.43M | 7.23M | 6.98M |
| Total Finance Division Other Current Liabilities | 10.58M | 20.52M | 21.10M | 24.39M | 22.63M |
| Total Other Current Liabilities | 10.58M | 20.52M | 21.10M | 24.39M | 22.63M |
| Total Current Liabilities | 35.50M | 41.98M | 40.21M | 49.79M | 44.21M |
|
|
|||||
| Total Current Liabilities | 35.50M | 41.98M | 40.21M | 49.79M | 44.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 30.52M | 32.57M | 34.57M | 36.50M | 38.37M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.47M | 3.61M | 5.76M | 7.00M | 13.15M |
| Total Liabilities | 68.49M | 78.16M | 80.54M | 93.29M | 95.73M |
|
|
|||||
| Common Stock & APIC | 638.30M | 634.75M | 630.11M | 626.35M | 622.04M |
| Retained Earnings | -418.48M | -390.59M | -357.21M | -326.18M | -291.70M |
| Treasury Stock & Other | 7.00K | -221.00K | -199.00K | -407.00K | -33.00K |
| Total Common Equity | 219.83M | 243.94M | 272.70M | 299.76M | 330.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 219.83M | 243.94M | 272.70M | 299.76M | 330.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 219.83M | 243.94M | 272.70M | 299.76M | 330.31M |
|
|
|||||